| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 107,825 | 125,385 | 108,782 | 129,658 | | Cost of Revenue | 56,437 | 69,129 | 66,279 | 76,358 | | | Gross Profit | 51,388 | 56,256 | 42,503 | 53,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,857 | 29,419 | 31,263 | 37,596 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,783 | 3,562 | 3,330 | 3,719 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,748 | 23,275 | 7,910 | 11,985 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (709) | (1,371) | (66) | (141) | | Earnings Before Interest And Taxes | 16,039 | 21,904 | 7,844 | 11,844 | | Interest Expense | 91 | 98 | 110 | 104 | | Income Before Tax | 15,948 | 21,806 | 7,734 | 11,740 | | Income Tax Expense | 5,626 | 8,220 | 2,460 | 4,709 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,322 | 13,586 | 5,274 | 7,031 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,322 | 13,586 | 5,274 | 7,031 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,322 | $13,586 | $5,274 | $7,031 |
|
0.33% Nasdaq 
Income Statement
